Literature DB >> 1952174

Plasma inorganic fluoride concentrations during and after prolonged (greater than 24 h) isoflurane sedation: effect on renal function.

E M Spencer1, S M Willatts, C Prys-Roberts.   

Abstract

We studied the effect of prolonged sedation (greater than 24 h) with isoflurane on plasma inorganic fluoride concentrations and renal function in 60 critically ill patients allocated randomly to receive either isoflurane or midazolam for sedation. In the isoflurane group, plasma fluoride increased from a mean concentration of 3.1 mumol/L to 20.0 mumol/L at the end of sedation, continued to increase to a peak of 25.3 mumol/L 16 h later, and then decreased exponentially (t1/2 = 111 h) to reach normal levels by the fifth day. In the midazolam group, the plasma fluoride increased from a mean concentration of 4.2 mumol/L to a peak of 6.8 mumol/L 12 h after starting the sedation and then decreased toward normal. Serum and urinary electrolytes, urine osmolality, and creatinine clearance during and after sedation were similar in the two groups. Isoflurane sedation was associated with an increase in plasma fluoride concentration without any clinical deterioration of renal function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1952174     DOI: 10.1213/00000539-199112000-00010

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  [Sedation concepts with volatile anaesthetics in intensive care: practical use and current experiences with the AnaConDa system].

Authors:  J Kompardt; K Schärff; K Kubosch; C Pohl; M Bomplitz; J Soukup
Journal:  Anaesthesist       Date:  2008-12       Impact factor: 1.041

Review 2.  Volatile anesthetics and AKI: risks, mechanisms, and a potential therapeutic window.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

Review 3.  Inhaled anesthetic agent sedation in the ICU and trace gas concentrations: a review.

Authors:  Jennifer Herzog-Niescery; Hans-Martin Seipp; Thomas Peter Weber; Martin Bellgardt
Journal:  J Clin Monit Comput       Date:  2017-08-31       Impact factor: 2.502

4.  Prolonged use of isoflurane in asthma.

Authors:  A Best; R Wenstone; P Murphy
Journal:  Can J Anaesth       Date:  1994-05       Impact factor: 5.063

Review 5.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

6.  Volatile Anesthetics and the Treatment of Severe Bronchospasm: A Concept of Targeted Delivery.

Authors:  Jarred R Mondoñedo; John S McNeil; Samir D Amin; Jacob Herrmann; Brett A Simon; David W Kaczka
Journal:  Drug Discov Today Dis Models       Date:  2014-04-29

7.  Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety.

Authors:  E M Spencer; S M Willatts
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

8.  Sedation with sevoflurane in postoperative cardiac surgery: influence on troponin T and creatinine values.

Authors:  J M Marcos-Vidal; R González; C Garcia; C Soria; M Galiana; B De Prada
Journal:  Heart Lung Vessel       Date:  2014
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.